Vascular Disease Mayo Flashcards

1
Q

PAD: Background

A
  • Risk factors: smoking, DM, CAD, age
  • Do NOT screen if asymptomatic
  • Classic claudication ~10%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PAD: ABI

A

Highest ankle pressure / highest brachial pressure (right or left)

If borderline, exercise ABI:
- abnormal if ABI decreases by 20%
- abnormal if ankle pressure >30mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PAD: chronic critical limb ischemia

A

-Symptoms >2 weeks
-Rest pain, ischemic ulcers, gangrene, elevation pallor/dependent rubor
-High risk of amputation
-Tx: early revascularization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Thromboangiitis obliterans

A

-Buerger’s disease
-M>F, age<40, tobacco use
-Superficial thrombophlebtiis at distal>prox vessels
-Tx smoking cessation, iloprost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mesenteric ischemia

A

-Acute arterial->acute abd pain

-Chronic arterial->nausea, weight loss

-Venous thrombus->less abrupt onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PAD: Treatment

A

MEDICAL THERAPY
Class 1:
- Statin (also evolocumab-PCSK9)
- Anti-hypertensive (ACEi)
- DM (GLP1, SGLT2)
- Smoking cessation
- Foot care
- COVID/flu vaccines
- Cilastazol if symptomatic (contraindicated in heart failure)
- Anti-thrombotic and/ anti-platelet if symptomatic
Class 2:
- Single agent anti-platelet if asymptomatic

EXERCISE THERAPY
REVASCULARIZATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PAD: Treatment- antiplatelet, antithrombotic

A

No recent revasc:
- Single anti-platelet (ASA 75-325mg, Clopidogrel) OR low dose asa + rivaroxaban 2.5mg BID

Recent revasc:
- Low dose asa + rivaroxaban 2.5mg BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PAD: Revascularization

A

By location:
- Aortoiliac, femoropopliteal stenosis = endovascular (class 1)
- Common femoral = endarterectomy, endovascular (class 2a)
- Infrapopliteal (Class 2b)

By disease type:
- Chronic limb threatening ischemia (CLTI) = Class 1 to revasucularize

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PAD: Acute limb ischemia

A

Cx: embolus, thrombosis, dissection, trauma
S/S: pallor, pain, paresthesia, paralysis, pulselessness, poikilothermia. Less than 2 weeks.
Tx: heparin infusion, revascularization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AAA: background

A

Aorta >3cm
Screen with US
Risk factors: first degree fam hx (class 1), smoking history
in men 65-75 (class 1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

AAA: Surveillance US

A

Indications for repair:
- women >5cm
- men >5.5cm
- 1cm/year

US every 6 months when close to these thresholds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AAA: Management

A

Blood pressure management
Aspirin
Statin
Smoking cessation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

AAA: open surgical vs endovascular repair (EVAR) for infra-renal AAA

A

Open repair
Pros: fewer complications

Endovascular repair
Pros: fewer procedural mortality, follow up imaging. Cons: endoleaks–>aneurysm can still grow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Acute aortic syndrome: types

A
  1. Penetrating atherosclerotic ulcer = penetrates the internal elastic lamina
  2. Intramural hematoma = hemorrhage within the media
  3. Aortic dissection = tear in intima with false lumen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acute aortic syndrome: symptoms

A

Hemorrhage within the media

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acute aortic syndrome: management

A

-SBP goal <120mmhg, HR goal 60-80
-Avoid meds with reflex tachycardia (nitros)
-Analgesia
-Surgery?
—Type A goes to surgery
—Type B goes to surgery if persistent pain, propagation, malperfusion of organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sporadic aortic aneurysm

A

Ddx: inflammatory, familial, syndromic, bicuspid

Risk factors: old ago, atherosclerosis, HTN

Management: BP control (beta blocker), lipid control, smoking cessation

Surgery indications:
- 5.5cm or more
- rapid growth >5mm/year
- 4.5cm at time of surgery/CABG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Genetic aortopathy: familial (nonsyndromic)

A
  • Nonsyndromic (phenotypically normal)
  • Diagnosed later (50s)

Management:
- Standard medical
- Genetic testing 3-5 yrs
- Screen first degree relatives
- Surgery if aorta >4.5-5.0cm

19
Q

Genetic aortopathy: Syndromic-Marfan

A

Syndromic (phenotype)

FBN1. Fibrillin malformed-activates TGFBR–>loss of collagen, elastic tissue

S/S: partial lens dislocation, pectus excavatum, skin striae, scoliosis, arachnodactyly

Management:
- Standard medical
- Genetic testing 3-5 yrs
- Screen first degree relatives
- Surgery if aorta >4.5-5.0cm

20
Q

Genetic aortopathy: Syndromic-Loey Dietz

A

Similar mechanism as Marfan, different gene (TGFBR or SMAD). Auto dom

Elevated IgE levels

S/S: abdominal pain, food allergies

Management:
- Standard medical
- Genetic testing 3-5 yrs
- Screen first degree relatives
- Surgery if aorta >4.0cm
- Annual surveillance of vasculature

21
Q

Genetic aortopathy: Syndromic-Ehlers Danlos

A

Issue with collagen. Auto dom

S/S: wide space eyes, thin skin (can see vesvels), pretibial scar

Can dissection at normal caliber

Management:
- Standard medical
- Genetic testing 3-5 yrs
- Screen first degree relatives
- Surgery if aorta >4.0cm
- Annual surveillance of vasculature

22
Q

Genetic aortopathy: Syndromic-Bicuspid

A

Auto dom
Most common
50-80% develop aortic aneurysm

Turner: short, unable to conceive, ejection click and systolic murmur

Management:
- Standard medical
- Genetic testing 3-5 yrs
- Screen first degree relatives
- Surgery if aorta >5.5cm
- Annual surveillance of vasculature

23
Q

Inflammatory aortopathy: GCA

A

GCA>50yr

Arterial wall inflammation

S/S: morning stiffness, fatigue, weight loss, headache, elevated ESR
+PET

50% have aortopathy, 1/3 dissect at low size

24
Q

Inflammatory aortopathy: Takayasu

A

Takayasu<50yr

S/S: arm.leg claudication, reduced upper extremity pulses, vascular bruit, carotid abnormality

25
Aortic aneurysm: background
Types: - sporadic - familial - syndromic - bicuspid -inflammatory Aortic media: elastic fibers, collagen, smooth msucle
26
Aortopathy: Meds to avoid
Fluroquinolones and CCB
27
DVT: acute vs chronic
Acute DVT - Distended - No color, hypoehoic - Noncompressible Chronic post-thrombotic changes - Thickened wall - Partially compressible - Small caliber - internal webs (chronic scar with no embolic potential) - NO anticoagulation needed
28
DVT: Diagnostic
If high pretest probabilty, then treat while organizing imaging for confirmation
29
PE: Diagnostic
If high pretest probabilty, then treat while organizing imaging for confirmation
30
PE: CTA
Filling defects on CTA
31
DVT and PE: general management
If high pretest probabilty, then treat while organizing imaging for confirmation LMWH or fondaparinux (over UFH) Provoked - Treatment for 3 months Unprovoked - Extended phase AC with reduced dose DOAC at 6 months of treatment
32
HIT
Monitor plt with UFH (>4days). DO NOT monitor plt with LMWH or fondapariux Treatment: - Stop heparin - 4T - hep factor 4 elisa - serotonin release assay - start direct thrombin inhibitior --> argatroban, bivalirudin - warfarin only after plt recovers
33
Uspstf: who gets abd aorta US?
65-75yo men, current/former smoker
34
Subclavian steal
S/S: prox subclavian stenosis Ipsilateral vertebral artery flow reversal BP difference in arms
35
DVT on US
ACUTE Distended Non-compressible Absent color Hypoechoic CHRONIC Thickened wall Partially compressible Small caliber Internal webs
36
AC for DVT/PE
LMWH and Fondaparinux >> UFH
37
HIT: dx and tx
Dx - 4T (thrombocytopenia, thrombosis, timing) other - Heparin platelet factor 4 (SRA) Tx - Direct thrombin inhibitor (argatroban, bivalirudin) - Warfarin (after platelet recovery) - DOAC
38
Extended therapy
Unprovoked Extended phase = lifetime with reduced dose DOAC (apixaban or rivaroxaban) Start at 6 months Compared to provoked treatment of 3 months
39
PE: Thrombolytics
- For massive PE / unstable patients - use thrombylytics - Systemic lysis > catheter directed lysis (EKOS, INDIGO, FlowTriever) Submassive PE treated conservatively
40
APS
Dx: - Thrombocytopenia, prolonged PTT, hx thrombosis, miscarriage, connective tissue disease Tx Warfarin (INR 2.5) > DOAC
41
Lymphedema
Dx Lymphoscintigram Tx Compression Manual lymphatic drainage Intermittent pnuematic pumping
42
Atypical DVT
- Organ associated with drainage--cancer?
43
Noncontrast CT head: bleed vs infarct
44